Meeting
2023 ASCO Annual Meeting
Gynecologic-cancer analysis of ARID1A alterations detected in tissue and liquid biopsies.
Authors
Natalie Danziger
Foundation Medicine, Inc., Cambridge, MA
Natalie Danziger , Elise C. Kohn , Julia C. F. Quintanilha , Gerald Li , Julia A Elvin , Douglas I. Lin
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gynecologic Cancer
Track
Gynecologic Cancer
Sub Track
Ovarian Cancer
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 5593)
DOI
10.1200/JCO.2023.41.16_suppl.5593
Abstract #
5593
Poster Bd #
288
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Comprehensive genomic profiling (CGP) of chromophobe renal cell carcinoma (chrRCC) compared with non-chromophobe RCC (nonchrRCC): Impact of FLCN genomic alteration (GA) status.
First Author: Gennady Bratslavsky
Poster
2023 ASCO Annual Meeting
The effect of ctDNA tumor fraction (TF) on overall survival and concordance between tissue genomics and ctDNA in Lung-MAP.
First Author: Philip C. Mack
Poster
2023 ASCO Annual Meeting
Blood-based assessment of patients with mismatch repair-deficient tumors enrolled in NCI-MATCH Arm Z1D (nivolumab).
First Author: Chris Alan Karlovich
Poster
2022 ASCO Annual Meeting
Impact of RAS mutations on immunologic characteristics of the tumor microenvironment (TME) in patients with microsatellite instability-high (MSI-H) or mismatch-repair–deficient (dMMR) colorectal cancer (CRC).
First Author: Mohamed E. Salem